The Beauty Health (SKIN): O‘sishni hisobga olgan narx-foyda koeffitsiyenti
The Beauty Health HydraFacial tizimlari yetkazib berish orqali daromad keltiradi, bunda apparat savdosi yuqori marjali sarflanadigan materiallarning takroriy savdosi bilan birlashtirilgan. P/E o'sish ko'paytirgichi tendentsiyasi foyda nisbatidagi aktivlar qiymati dinamikasini aks ettiradi, bunda ko'rsatkich 0.00 darajasida qotirilgan. Syndeo yangilanishi va aksiyalarni qayta sotib olish o'sish potentsialini ta'minlasa-da, iste'molchilarning spa xizmatlariga sarflayotgan mablag'larining kamayishi kompaniyani narxlarni pasaytirishga majbur qilmoqda.
The Beauty Health (SKIN) kompaniyasining tahliliy kesimlari
- joriy kotirovkalar va o'rtacha qiymat prognozi:
- birja kapitallashuvi ma'lumotlari:
- biznesning balans baholash tafsilotlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Barcha qarzlarning o‘z mablag‘lariga nisbati The Beauty Health|SKIN - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati Beauty Health|SKIN - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati The Beauty Health Company|SKIN - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzi BeautyHealth|Shoshilinch likvidlik beautyhealth.com
- foyda va bozor koeffitsiyentlari statistikasi:
SKIN - Sof foyda|Prognoz qilingan kelajakdagi foyda The Beauty Health|SKIN - Narx-foyda koeffitsiyenti|Forvard P/E multiplikatori Beauty Health|SKIN - Narx-foyda va o‘sish multiplikatori|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati koeffitsiyenti The Beauty Health Company|SKIN - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda BeautyHealth|SKIN - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi beautyhealth.com|SKIN - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi The Beauty Health
- sotishdan tushum va biznes daromadlari ko'rsatkichlari:
Kompaniyaning jamlanma tahliliyoti:Beauty Health, SKIN
The Beauty Health (SKIN) HydraFacial ning yopiq B2B modeli hisobiga barqaror kengayishni saqlab qolmoqda, bu model maxsus sarf materiallaridan foydalanishni talab etadi va ushbu tendentsiya PEG koeffitsiyenti dinamikasida aks etgan. Ushbu koeffitsient P/E koeffitsiyentini foyda o'sish sur'atlari bilan solishtiradi, bunda birdan past qiymatlar aktivning kengayishiga nisbatan qadrsizlanganligini anglatadi va ushbu grafikni tasdiqlangan o'sish potentsialiga ega yuqori rentabelli "raketalar"ni aniqlash vositasiga aylantiradi.
Raqobatdosh kompaniyalar
HCA Holdings - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Tenet - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati FMS (Fresenius Medical Care)|SOLV: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Encompass Health Corp|Universal Health Services (UHS) - Narxning foydaga va o‘sish sur’atiga nisbati|DaVita Inc. (DVA) - PEG multiplikatori|RDNT (RadNet Management) - PEG multiplikatori|Option Care Health, Inc. - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Surgery Partners (SGRY)|PINC - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati nationalvision.com EYE|Narxning sof foyda o‘sishiga nisbati Progyny, Inc.|ARDT - Narxning foydaga va o‘sish sur’atiga nisbati|Select Medical Holdings - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|Apollo Medical Holdings (ASTH) - Narxning foydaga va o‘sish sur’atiga nisbati|MD - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|USPH (usph.com) - PEG multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti PNTG (The Pennant Group Corp)|PEG multiplikatori ORGO|NUTX - O‘sish sur’atiga tuzatilgan narx-foyda|aunainvestors.com - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori SBC Medical Group Holdings Inc. SBC|Evolus Corp - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti CYH (Community Health Systems Inc)|MediWound Ltd (MDWD) - Narxning foydaga va o‘sish sur’atiga nisbati|BTMD - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati The Joint|Narx-foyda va o‘sish multiplikatori DocGo (DCGO)|P3 Health Partners, Inc. (PIII) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori Gain Therapeutics (GANX)|PEG multiplikatori EUDA (EUDA Health)|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti BMGL|CollPlant Ltd - PEG multiplikatori|Narxning sof foyda o‘sishiga nisbati Cuprina Holdings (Cayman) Ltd. (CUPR)|Concord Medical Corp (CCM) - Narxning foydaga va o‘sish sur’atiga nisbati|ASHS - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati MEDIROM Healthcare Group|PEG multiplikatori avalon-globocare.com|PEG multiplikatori DHAI|XAGE (Carmell Therapeutics Corporation) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati NewGenIvf Corp NIVF|ATIP (atipt.com) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|CareMax, Inc - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti KDLY (Kindly MD, Inc.)|MODV: PEG multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti NVOS|Narxning foydaga va o‘sish sur’atiga nisbati SunLink Health Systems, Inc.|PEG multiplikatori IMAC Holdings, Inc.
